Quick Answer
Green Tea Cognition Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: For risk of bias assessment, the Cochrane Risk of Bias Tool (version 2.0) was used.
Key Takeaways
- 01For risk of bias assessment, the Cochrane Risk of Bias Tool (version 2.0) was used. [Mátyus RO (2025)]
- 02Background: Green tea ( Camellia sinensis ) has been consumed for centuries, and its beneficial effects on human health have been studied in recent decades. [Mátyus RO (2025)]
- 03l-theanine, an active ingredient in green tea, has been used to improve cognition and mood. [Mátyus RO (2025)]
- 04This study consolidates the evidence based on phytochemicals for cognitive enhancement, highlighting a need for more robust, methodologically sound trials to determine if these natural compounds hold promise in cognitive therapeutics, particularly for populations with cognitive impairments. [Marsh Alexander (2026)]
The current Migaku evidence database contains 2 reusable source documents for Green Tea Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- For risk of bias assessment, the Cochrane Risk of Bias Tool (version 2.0) was used. [Mátyus RO (2025); evidence level 1]
- Background: Green tea ( Camellia sinensis ) has been consumed for centuries, and its beneficial effects on human health have been studied in recent decades. [Mátyus RO (2025); evidence level 1]
- l-theanine, an active ingredient in green tea, has been used to improve cognition and mood. [Mátyus RO (2025); evidence level 1]
- This study consolidates the evidence based on phytochemicals for cognitive enhancement, highlighting a need for more robust, methodologically sound trials to determine if these natural compounds hold promise in cognitive therapeutics, particularly for populations with cognitive impairments. [Marsh Alexander (2026); evidence level 3]
- Accordingly, this review prespecified phytochemicals that meet 3 criteria: long-standing traditional association with cognition, biological plausibility supported by preclinical evidence, and progression into human research or commercial cognitive-health formulations, includingL. [Marsh Alexander (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources